在皮肤癌新辅助系统治疗时代的外科教科书成果
Piotr Jan Błoński1,2,3, Piotr Rutkowski1, Krzysztof Ostaszewski1
1Department of Soft Tissue/Bone Sarcoma and Melanoma, National Research Institute of Oncology, 02-781 Warsaw, Poland.
Journal of clinical medicine
|November 27, 2024
概括
针对晚期皮肤癌的新系统性治疗方法提高了外科手术的结果. 这篇评论探讨了新辅助疗法.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 皮肤病学 皮肤病学
背景情况:
- 现在可用于局部晚期或转移性皮肤癌的新型全身治疗方法.
- 新辅助系统治疗可以简化手术切除,减少复杂性,并可能避免手术.
- 整合系统治疗与外科手术实践需要新的质量指标.
研究的目的:
- 审查新辅助性皮肤癌治疗的最新进展.
- 讨论这些治疗对外科手术程序的影响.
- 在教科书成果 (TO) 的框架内对这些变化进行上下文化.
主要方法:
- 关于皮肤癌新辅助系统治疗的最新发现的文献综述.
- 对外科手术管理的影响分析.
- 讨论教科书成果作为质量衡量的相关性.
主要成果:
- 新辅助性系统性治疗促进了手术切除,可能导致较少的广泛手术甚至非手术管理.
- 教科书成果提供了一种新的,直观的手术质量衡量方法,反映了短期结果和长期生存.
- 系统治疗和手术的整合需要调整质量评估工具,如TO.
结论:
- 新辅助系统治疗的最新进展正在改变皮肤癌的外科手术方法.
- 教科书成果为评估多学科癌症护理时代的外科质量提供了有价值的框架.
- 需要进一步研究和实施新的质量措施,以优化患者的治疗结果.
相关概念视频
Skin Cancer
3.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.7K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


